132 related articles for article (PubMed ID: 1682519)
1. Significance of immunohistochemically detected c-erbB-2 protein expression in stage III breast cancer, with reference to nuclear deformity, DNA content and prognosis.
Tamura G; Maesawa C; Mikawa S; Satodate R
Jpn J Clin Oncol; 1991 Aug; 21(4):264-7. PubMed ID: 1682519
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer.
Schimmelpenning H; Eriksson ET; Falkmer UG; Rutqvist LE; Johansson H; Fallenius A; Auer GU
Eur J Surg Oncol; 1992 Dec; 18(6):530-7. PubMed ID: 1362164
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma.
Freeman JW; McGrath P; Bondada V; Selliah N; Ownby H; Maloney T; Busch RK; Busch H
Cancer Res; 1991 Apr; 51(8):1973-8. PubMed ID: 1672621
[TBL] [Abstract][Full Text] [Related]
4. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.
Wilbur DC; Barrows GH
Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay.
Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
Jpn J Clin Oncol; 1994 Apr; 24(2):74-8. PubMed ID: 7908994
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
8. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
Nesland JM; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen AL
Anticancer Res; 1991; 11(1):161-7. PubMed ID: 1673329
[TBL] [Abstract][Full Text] [Related]
9. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
[TBL] [Abstract][Full Text] [Related]
11. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
Li BD; Bauer KD; Carney WP; Duda RB
J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
[TBL] [Abstract][Full Text] [Related]
12. C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast.
Lilleng R; Hagmar BM; Nesland JM
Mod Pathol; 1992 Jan; 5(1):41-7. PubMed ID: 1347423
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer.
Giai M; Roagna R; Ponzone R; De Bortoli M; Dati C; Sismondi P
Anticancer Res; 1994; 14(3B):1441-50. PubMed ID: 7915096
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
[TBL] [Abstract][Full Text] [Related]
15. c-erbB-2 amplification in node-negative human breast cancer.
Ro JS; el-Naggar A; Ro JY; Blick M; Frye D; Fraschini G; Fritsche H; Hortobagyi G
Cancer Res; 1989 Dec; 49(24 Pt 1):6941-4. PubMed ID: 2573424
[TBL] [Abstract][Full Text] [Related]
16. Analysis of c-erbB-2 protein expression in conjunction with DNA content using multiparameter flow cytometry.
Kelsten ML; Berger MS; Maguire HC; Chianese DA; Hellman ME; Weiner DB; Greene MI
Cytometry; 1990; 11(4):522-32. PubMed ID: 2188818
[TBL] [Abstract][Full Text] [Related]
17. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
Berger MS; Locher GW; Saurer S; Gullick WJ; Waterfield MD; Groner B; Hynes NE
Cancer Res; 1988 Mar; 48(5):1238-43. PubMed ID: 2893663
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer.
Nakopoulou LL; Alexiadou A; Theodoropoulos GE; Lazaris AC; Tzonou A; Keramopoulos A
J Pathol; 1996 May; 179(1):31-8. PubMed ID: 8691341
[TBL] [Abstract][Full Text] [Related]
20. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
Heintz NH; Leslie KO; Rogers LA; Howard PL
Arch Pathol Lab Med; 1990 Feb; 114(2):160-3. PubMed ID: 1967929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
